Categories AlphaGraphs, Earnings, Health Care
AMGN Infographic: Amgen’s Q4 2022 profit drops on flat revenues
Amgen Inc. (NASDAQ: AMGN) said its revenues remained unchanged in the fourth quarter of 2022 when the biotechnology firm’s earnings declined.
Unadjusted earnings decreased to $4.09 per share in the December quarter from $4.40 per share in the year-ago period. The reported net income was $1.62 billion or $3.0 per share in the latest quarter, compared to $1.90 billion or $3.36 per share in the year-ago quarter.
Meanwhile, total revenues remained unchanged at $6.84 billion during the three-month period. A 4% increase in product sales was offset by weakness in the other business segments.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%
